Glucocorticoidlike activity of megestrol: A summary of food and drug administration experience and a review of the literature

Archives of Internal Medicine

Volumn 157, Issue 15, 1997, Pages 1651-1656

  Mann, Marianne ^a   Koller, Elizabeth ^a   Murgo, Anthony ^a   Malozowski, Saul ^a   Bacsanyi, Janos ^a   Leinung, Matthew ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ATENOLOL; CHOLINE MAGNESIUM TRISALICYLATE; CLOTRIMAZOLE; CORTICOTROPIN; COTRIMOXAZOLE; DAPSONE; DICLOFENAC; DIDANOSINE; ENALAPRIL MALEATE; FUROSEMIDE; GLUCOCORTICOID; HYDROCHLOROTHIAZIDE; INSULIN; LEVOTHYROXINE SODIUM; MEGESTROL ACETATE; METOPROLOL; PENTAMIDINE; PYRIMETHAMINE; QUININE SULFATE; TAMOXIFEN CITRATE; TOLMETIN; VERAPAMIL; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL INSUFFICIENCY; CACHEXIA; CANCER; CUSHING SYNDROME; DIABETES MELLITUS; DRUG ACTIVITY; HUMAN; HYPERGLYCEMIA; PRIORITY JOURNAL; REVIEW;

EID: 0030798163     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.15.1651     Document Type: Review

References (23)

1. Steer KA, Kurtz AB, Honour JW. Megestrol-induced Cushing's syndrome. Clin Endocrinol (Oxf). 1995;42:91-93.
2. Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med. 1992;116:53-54.
3. Panwalker AP. Hyperglycemia induced by megestrol acetate. Ann Intern Med. 1992;116:878.
4. Salinas I, Lucas A, Clotet B. Secondary diabetes induced by megestrol acetate therapy in a patient with AIDS-associated cachexia. AIDS. 1993; 7:894.
5. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 1995;122:843-845.
6. Maurer M. Megestrol for AIDS-related anorexia. Ann Intern Med. 1995;122:880.
7. Johnson DE, von Eschenbach AC, Babaiian RJ, Wishnow KI, Swanson DA, Tenney D. Medical castration using megestrol acetate and minidose estrogen. Urology. 1988;31:371-374.
8. Nathwani D, Green ST, Heslop J, Goldberg DJ, Kennedy DH. Beneficial response to megoestrol acetate in AIDS-related cachexia and a possible megoestrol withdrawal-associated syndrome? Acta Derm Venereol. 1990;70:520-521.
9. Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor. Biochem Pharmacol. 1983;32:1511-1518.
10. Watson AD, Church DB, Emslie DR, Middleton DJ. Comparative effects of proligestone and megestrol acetate on basal plasma glucose concentrations and cortisol responses to exogenous adrenocorticotrophic hormone in cats. Res Vet Sci. 1989;47:374-376.
11. Peterson ME. Effects of megestrol acetate on glucose tolerance and growth hormone secretion in the cat. Res Vet Sci. 1987;42:354-357.
12. Middleton DJ, Watson ADJ, Howe CH, Caterson ID. Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess in cats during therapy with megestrol acetate and prednisolone. Can J Vet Res. 1987; 51:60-65.
13. Willemse PHB, Kikkeschei LD, Tjabbes T, van Veelen H, Sleifjer DT. Adrenal stenoses as parameters of the bioavailability of MA and MPA. Eur J Cancer. 1990;26:359-362.
14. Briggs MH, Briggs M. Glucocorticoid properties of progestins. Steroids. 1973;22:555-559.
15. Alexieva-Figusch J, Blankenstein MA, de Jong FH, Lamberts SWJ. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. Eur J Cancer. 1984;20:1135-1140.
16. Alexiceva-Figusch J, Blankenstein MA, Hop WCJ, et al.Treatment of metastatic breast cancer patients with different dosages of megestrol acetate: dose relations, metabolic and endocrine effects. Eur J Cancer. 1984;20:33-40.
17. Heim W, Wright R, LaLuna F, Scialla S, Shelbaugh D. Adrenal suppressive effect of megestrol acetate in women with metastatic breast carcinoma. Proc Annu Meet Am Soc Clin Oncol. 1984; 3:21. Abstract.
18. Loprinzi CL, Jensen MD, Jiang H, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc. 1992;67:1160-1162.
19. Siminoski K, Goss P, Drucker DJ. The Cushing syndrome induced by medroxyprogesterone acetate. Ann Intern Med. 1989;111:758-760.
20. Willemse PHB, Van der Ploeg E, Sleijfer DT, Tjabbes T, Van Veelen H. A randomized comparison of megestrol acetate and medroxyprogesterone acetate in patients with advanced breast cancer. Eur J Cancer. 1990;26:337-343.
21. Oster MH, Enders SH, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994;121:400-408.
22. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994;121:393-399.
23. Rowland KM, Jett JR, Jung SH, Loprinzi CL, Washburn HJ, Shaw EG. Phase III randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive stage small cell lung cancer: a North Central Cancer Treatment Group study. Proc Annu Meet Am Soc Clin Oncol. 1994;13:330. Abstract.